Molecular cloning and gonadotropin-dependent regulation of equine prostaglandin F2alpha receptor in ovarian follicles during the ovulatory process in vivo.

The research primarily investigates the role and regulation of the prostaglandin F2alpha receptor (FP) in ovulation processes in horses. The researchers found that the FP receptor is regulated in a unique way in different types of follicular cells, offering insights for further understanding of ovulation.

Objective and Background

• The study sets out to elucidate the regulation of the prostaglandin F2alpha receptor (FP) during ovulation, a subject that had not been explored in-depth.
• It aims to examine and characterize equine FP and its response to gonadotropins, hormones that play a vital role in ovulation, in pre-ovulatory follicles.
• The study is premised on the knowledge that gonadotropin levels rise prior to ovulation, resulting in a significant increase in intrafollicular levels of prostaglandin F2alpha (PGF2alpha). This substance is known to interact with the FP receptor, but the details of this interplay are not well understood.

Methodology

• The researchers used methods like molecular cloning, semi-quantitative RT-PCR/Southern blot, and immunohistochemistry to examine the expression and regulation of FP in horses.
• FP mRNA expression was analyzed in follicles obtained both before and after hCG treatment at various time intervals.
• The study also involved examination of FP protein induction post-hCG treatment.

Findings

• The researchers characterized the full-length equine FP as a 366-amino acid protein, noting similarities (82-93% homology) with other species.
• It was found that FP mRNA expression was low in follicles prior to hCG treatment but increased at specific intervals post-treatment.
• Notably, the researchers discovered that FP expression is regulated differently in granulosa cells and theca cells (two types of cells in the ovarian follicles) at different times post-hCG treatment.
• In both types of follicular cells, the induction of FP protein was confirmed after hCG treatment. Furthermore, they identified an increase in FP protein in preovulatory follicles 36hrs post-hCG.
• FP mRNA was detected in high levels in the corpora lutea and heart, but was very low or completely undetectable in other tissues.

Conclusion

• The study was vital in shedding light on how the FP receptor is regulated by hCG in preovulatory follicles prior to ovulation in equines. This control was discovered to be species-specific, indicating variation in ovulatory processes across different species.
• The findings suggest a potential involvement of PGF2alpha, acting on granulosa and theca cells, in the ovulatory process. This can be a prospective area for further investigation to enhance the understanding of ovulation.